Emcure Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) had conducted surveillance inspection of Company's manufacturing facility located at Survey No. 485 (New), 160/P1 (Old), Kadu, Taluka - Lakhtar, District- Surendranagar, Gujarat - 382775, from 06 October 2025 to 10 October 2025. The inspection is concluded without any observation.
Powered by Capital Market - Live News